Related Experiment Video
Updated: May 8, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Potential Celiac Disease as a Window Into Gluten-Mediated Enteropathy
Alexa R Weingarden1, Nielsen Q Fernandez-Becker2
1Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN.
Journal of Clinical Gastroenterology
|May 6, 2026
Summary
Potential celiac disease, characterized by positive serology without intestinal damage, affects many patients. Further research is needed to understand its development and predict progression to active celiac disease.
Area of Science:
- Gastroenterology
- Immunology
- Celiac Disease Pathogenesis
Background:
- Potential celiac disease (PCD) is defined by positive celiac serology but no villous atrophy.
- This phenotype is prevalent, seen in approximately 20% of celiac patients.
- Many patients with PCD do not progress to active celiac disease and may even normalize antibodies while consuming gluten.
Purpose of the Study:
- To investigate the biochemical and immunologic differences between potential and active celiac disease.
- To gain insights into the developmental pathways of celiac disease.
- To identify potential therapeutic targets for preventing or treating villous atrophy.
Main Methods:
- The study involved analyzing biochemical and immunological markers in patients with potential and active celiac disease.
- Comparative analysis was performed to identify distinguishing factors.
- Further details on specific methodologies are not provided in the abstract.
Main Results:
- The abstract does not contain specific results.
- It highlights the lack of understanding regarding prediction of progression from potential to active celiac disease.
- It also notes the absence of clear management guidelines for potential celiac disease.
Conclusions:
- Understanding the differences between potential and active celiac disease may illuminate celiac disease development.
- Identifying these distinctions could reveal new pathways for therapeutic intervention.
- This research aims to find ways to prevent or reduce intestinal villous atrophy.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...